@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-RC3PND0F-S
  skos:prefLabel "ethnology (Qualifier)"@en, "ethnologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-VG20R78F-K
  skos:prefLabel "embryologie (Qualificatif)"@fr, "embryology (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-ZJBZVRWR-8
  skos:prefLabel "parasitologie (Qualificatif)"@fr, "parasitology (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-KFM33PF8-L
  skos:prefLabel "médecine vétérinaire (Qualificatif)"@fr, "veterinary (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-GXVR9QN8-P
  skos:prefLabel "drug therapy (Qualifier)"@en, "traitement médicamenteux (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-MDQBX560-1
  skos:prefLabel "radiotherapy (Qualifier)"@en, "radiothérapie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CSKTXWF5-F
  skos:prefLabel "epidemiology (Qualifier)"@en, "épidémiologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z8K53CBP-H
  skos:prefLabel "Basal Ganglia Diseases"@en, "Affections des ganglions de la base"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-K9P8KKTF-V .

jvr:-SDPG013V-D
  skos:prefLabel "psychology (Qualifier)"@en, "psychologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-KRXG97RR-5
  skos:prefLabel "diagnostic (Qualificatif)"@fr, "diagnosis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-WWJHCQRB-K
  skos:prefLabel "surgery (Qualifier)"@en, "chirurgie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z9TSGBXH-4
  skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-DH7H9MJ2-N
  skos:prefLabel "anatomopathologie (Qualificatif)"@fr, "pathology (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T6JZ48ZV-N
  skos:prefLabel "complications (Qualifier)"@en, "complications (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W4X1LN61-R
  skos:prefLabel "diet therapy (Qualifier)"@en, "diétothérapie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HPKB70N8-W
  skos:prefLabel "rehabilitation (Qualifier)"@en, "rééducation et réadaptation (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-B6C87218-T
  skos:prefLabel "prévention et contrôle (Qualificatif)"@fr, "prevention & control (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-WQ00QWRG-J
  skos:prefLabel "physiopathologie (Qualificatif)"@fr, "physiopathology (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6T67RP3-2
  skos:prefLabel "diagnostic imaging (Qualifier)"@en, "imagerie diagnostique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-BQ3W1P91-F
  skos:prefLabel "thérapie (Qualificatif)"@fr, "therapy (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-SDXQ5280-F
  skos:prefLabel "mortality (Qualifier)"@en, "mortalité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-XVHTZRCG-7
  skos:prefLabel "étiologie (Qualificatif)"@fr, "etiology (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-T1QJHLQ4-J
  skos:prefLabel "microbiology (Qualifier)"@en, "microbiologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-P31C9JZH-X
  skos:prefLabel "congénital (Qualificatif)"@fr, "congenital (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-F07P4QZ6-C
  skos:prefLabel "Neurotoxicity Syndromes"@en, "Syndromes neurotoxiques"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-K9P8KKTF-V .

jvr:-K9P8KKTF-V
  skos:prefLabel "Syndrome malin des neuroleptiques"@fr, "Neuroleptic Malignant Syndrome"@en ;
  mesh:allowableQualifier jvr:-T6JZ48ZV-N, jvr:-VG20R78F-K, jvr:-XV06LPML-W, jvr:-JVKFK2NX-2, jvr:-BT300B3G-Q, jvr:-KRXG97RR-5, jvr:-CSKTXWF5-F, jvr:-P1X8SCQ6-K, jvr:-BQ3W1P91-F, jvr:-CB30NGKB-3, jvr:-S0CS1X5R-5, jvr:-Z9TSGBXH-4, jvr:-SDXQ5280-F, jvr:-ZJBZVRWR-8, jvr:-XVHTZRCG-7, jvr:-W4X1LN61-R, jvr:-P31C9JZH-X, jvr:-L6C0XPHT-4, jvr:-GXVR9QN8-P, jvr:-RC3PND0F-S, jvr:-W6T67RP3-2, jvr:-SDPG013V-D, jvr:-HPKB70N8-W, jvr:-WWJHCQRB-K, jvr:-MDQBX560-1, jvr:-B6C87218-T, jvr:-WQ00QWRG-J, jvr:-T1QJHLQ4-J, jvr:-SBNWSM1T-R, jvr:-J9Z93VFN-9, jvr:-NHL3D2X0-S, jvr:-KFM33PF8-L, jvr:-W6SQV79N-S, jvr:-DH7H9MJ2-N ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D009459> ;
  skos:hiddenLabel "Neuroleptic-Malignant Syndrome, Neuroleptic Induced"@en, "Neuroleptic-Induced Neuroleptic Malignant Syndrome"@en, "Syndrome malin dû aux neuroleptiques"@fr, "Syndrome malin induit par les neuroleptiques"@fr ;
  a mesh:Descriptor, skos:Concept ;
  dc:established "1986-01-01"^^xsd:date ;
  skos:inScheme jvr: ;
  skos:altLabel "SMN (Syndrome Malin des Neuroleptiques)"@fr, "NMS (Neuroleptic Malignant Syndrome)"@en ;
  dc:modified "2010-06-25"^^xsd:date ;
  skos:definition "A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)"@en ;
  dc:created "1984-06-05"^^xsd:date ;
  skos:broader jvr:-F07P4QZ6-C, jvr:-Z8K53CBP-H .

jvr:-J9Z93VFN-9
  skos:prefLabel "enzymology (Qualifier)"@en, "enzymologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-P1X8SCQ6-K
  skos:prefLabel "virologie (Qualificatif)"@fr, "virology (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-JVKFK2NX-2
  skos:prefLabel "nursing (Qualifier)"@en, "soins infirmiers (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .